(Q34535915)

English

Infliximab for psoriasis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

Infliximab for psoriasis (English)

1 reference

Europe PubMed Central

2 August 2017

author name string

Alice B Gottlieb

1

1 reference

Europe PubMed Central

2 August 2017

language of work or name

0 references

publication date

1 August 2003

1 reference

Europe PubMed Central

2 August 2017

Journal of the American Academy of Dermatology

1 reference

Europe PubMed Central

2 August 2017

49

1 reference

Europe PubMed Central

2 August 2017

S112-7

1 reference

Europe PubMed Central

2 August 2017

2 Suppl

1 reference

Europe PubMed Central

2 August 2017

Cytokines and autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901143-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901143-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacodynamic and pharmacokinetic response to anti-tumor necrosis factor-alpha monoclonal antibody (infliximab) treatment of moderate to severe psoriasis vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901143-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical research helps elucidate the role of tumor necrosis factor-αin the pathogenesis of T1-mediated immune disorders: use of targeted immunotherapeutics as pathogenic probes

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901143-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901143-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunohistochemical studies of infiltrating cells in early and chronic lesions of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901143-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Dermal dendritic cells are important members of the skin immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901143-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Langerhans cells may trigger the psoriatic disease process via production of nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901143-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytokines and chemokines in the initiation and regulation of epidermal Langerhans cell mobilization

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901143-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased expression of adhesion receptors in both lesional and non-lesional psoriatic skin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901143-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Psoriasis as a model for T-cell-mediated disease: immunobiologic and clinical effects of treatment with multiple doses of efalizumab, an anti-CD11a antibody.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901143-5

7 January 2021

based on heuristic

inferred from DOI database lookup

T-lymphocyte dependence of psoriatic pathology in human psoriatic skin grafted to SCID mice

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901143-5

7 January 2021

based on heuristic

inferred from DOI database lookup

T lymphocytes and monocytes bind to keratinocytes in frozen sections of biopsy specimens of normal skin treated with gamma interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901143-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytokine modulation of adhesion molecules in the regulation of immunologic cytotoxicity of epidermal targets

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901143-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Adhesion receptors of the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901143-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Structure, function, and molecular control of the skin lymphatic system

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901143-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Vasoactive intestinal peptide regulates its receptor expression and functions of human keratinocytes via type I vasoactive intestinal peptide receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901143-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulation of the level and glycosylation state of plasminogen activator inhibitor type 2 during human keratinocyte differentiation.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901143-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated tumour necrosis factor-alpha (TNF-alpha) biological activity in psoriatic skin lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901143-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment with anti-tumor necrosis factor alpha (TNF-alpha) monoclonal antibody dramatically decreases the clinical activity of psoriasis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901143-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901143-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Chimeric anti-TNF-alpha monoclonal antibody cA2 binds recombinant transmembrane TNF-alpha and activates immune effector functions

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901143-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901143-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901143-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901143-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Infliximab for the treatment of fistulas in patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901143-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901143-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Hidradenitis suppurativa and Crohn's disease: response to treatment with infliximab.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901143-5

7 January 2021

based on heuristic

inferred from DOI database lookup

RETRACTED: Infliximab in patients with primary Sjögren's syndrome: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901143-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Severe Psoriasis – Oral Therapy with a New Retinoid

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901143-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0190-9622(03)01143-5

1 reference

Europe PubMed Central

2 August 2017

release_zedbwq3qqfflxmd73mqt4ddy6m

1 reference

https://api.fatcat.wiki/v0/release/zedbwq3qqfflxmd73mqt4ddy6m

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

2 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34535915&oldid=1949668528"